Apolipoprotein A-I (apoA-I) stabilizes anti-atherogenic high density lipoprotein particles (HDL) in the circulation and governs their biogenesis, metabolism, and functional interactions. To decipher these important structure-function relationships, it will be necessary to understand the structure, stability, and plasticity of the apoA-I molecule. Biophysical studies show that lipid-free apoA-I contains a large amount of ␣-helical structure but the location of this structure and its properties are not established. We used hydrogen-deuterium exchange coupled with a fragmentation-separation method and mass spectrometric analysis to study human lipid-free apoA-I in its physiologically pertinent monomeric form. The acquisition of Ϸ100 overlapping peptide fragments that redundantly cover the 243-residue apoA-I polypeptide made it possible to define the positions and stabilities of helical segments and to draw inferences about their interactions and dynamic properties. Residues 7-44, 54 -65, 70 -78, 81-115, and 147-178 form ␣-helices, accounting for a helical content of 48 ؎ 3%, in agreement with circular dichroism measurements (49%). At 3 to 5 kcal/mol in free energy of stabilization, the helices are far more stable than could be achieved in isolation, indicating mutually stabilizing helix bundle interactions. However the helical structure is dynamic, unfolding and refolding in seconds, allowing facile apoA-I reorganization during HDL particle formation and remodeling.
T he incidence of coronary artery disease is inversely related to the plasma level of HDL, which mediates the reverse transport of cholesterol from peripheral cells to the liver for excretion (1, 2) . The biogenesis, metabolism, and transport of antiatherogenic HDL particles and their functional interactions are governed by the principal protein component, apolipoprotein A-I (apoA-I) (3, 4) . Lipid-free apoA-I can interact with a cell surface lipid transporter (ABCA1) to mediate the efflux of cellular phospholipid and cholesterol and the creation of nascent HDL particles (5). ApoA-I is then able to reorganize to accommodate and solubilize the lipids in different configurations of HDL particles as they mature. In the lipid-bound state, apoA-I governs lipid transport, receptor recognition, and other functions including the activation of lecithin-cholesterol acyltransferase, which converts cholesterol to cholesteryl ester (6) .
Widespread efforts to dissect these important functional relationships are presently restricted by our limited understanding of lipoprotein and apolipoprotein structure (3, 7) . Crystallographic study of the microemulsion-like HDL complexes appears to be impossible. Secondary structure prediction suggests 11 amphipathic ␣-helical segments in human apoA-I (8) . Biophysical studies distinguish an N-terminal highly helical domain (residues 1-189) and a more flexible C-terminal domain (residues 190-243) (for reviews see refs. 3, 4, 9) . A crystallographic study (10) of lipid-free apoA-I finds ␣-helix bundles in both domains but the helical content of Ϸ80% is markedly higher than the 50-60% helical content found by circular dichroism (CD) for the monomeric protein at low concentration (11) (12) (13) .
We used a fragmentation-separation hydrogen exchange (HX) method (14) with analysis by mass spectrometry (MS) (15) (16) (17) to study the human apoA-I molecule in its monomeric, lipid-free, conformation at low concentration (0.07 mg/mL; 2.5 M). The acquisition and HX rate analysis of about 100 overlapping fragments that redundantly cover the entire 243-residue length of apoA-I made it possible to define the positions of its several helices in the lipid-free state and their stability in real free energy terms. These same methods will be directly applicable to structure-function studies of other members of the large apolipoprotein family and their complexes with lipids.
whether the site in question is deeply buried or at the solventexposed protein surface. It is commonly believed that exchange requires that the protecting H-bond must be transiently broken and the hydrogen brought out into contact with solvent where it is susceptible to attack by solvent HX catalyst, namely hydroxide ion under the present conditions. H-bond breakage can be achieved by small ''local fluctuation'' reactions that may expose as little as a single amide (24) or by larger cooperative unfolding reactions ranging from a part or all of a particular secondary structural element (25) up to whole molecule unfolding (26) . Therefore the acquisition and analysis of HX data can in principle define structure and its stability and dynamical properties.
The plan of the HX experiments is illustrated in Fig. 1 and described in Methods (SI Materials and Methods). Timedependent H-to-D exchange throughout the apoA-I molecule was measured at the segment level in the many peptide fragments obtained in the proteolysis/mass spectrometry analysis. HX data shown in Fig. 2 and Fig. S3 for peptide fragments obtained for monomeric apoA-I in solution at pD 7.0 and 5°C illustrate the quality of the data and its analysis. The complete HX data set for Ϸ100 overlapping segments at pD 7.0 and 5°C is displayed in Fig. S3 and for pD 7.0 and 25°C in Fig. S4 . Results obtained at 25°C (Fig. S4) found that exchange for many sites was too fast to measure. Results at 5°C where the intrinsic chemical HX rate is slower by 10-fold are more informative (Fig.  S3) .
In each data panel a reference curve indicates the summed exchange behavior expected (27) for that peptide when in an unprotected (random coil) state. The reference curve is drawn as a stretched exponential D t ϭ N [1-exp(Ϫk ex t) ␤ ] rather than a simple exponential to accommodate the spread in intrinsic chemical HX rates of the various amides in any given segment because of different side chains, as described in Methods (SI Materials and Methods). For most peptides, the stretching factor (␤) falls in the narrow range 0.80 Ϯ 0.1, with a few outliers because of biased amino acid composition. The amplitude of the reference curve is equal to the number of amide hydrogens in the peptide minus the proline residues, which have no amide hydrogen, and it also assumes the loss during the analysis of deuterium label on the first two very rapidly exchanging Nterminal residues (except when residue 2 is Leu, Ile, or Val, which exchange more slowly and may retain some fractional label) (27) .
The HX data for some peptide fragments fall close to the reference curve indicating a lack of structural protection at those positions in the native apoA-I molecule, but for many peptides HX is much slower because of protection by H-bonding. The measured HX data were fit by stretched monoexponential curves, or by biexponential curves when necessary, using the stretching factor (␤) found for each peptide's reference curve. Nonmonoexponential behavior is especially pronounced when the peptide crosses an order/disorder boundary in the intact protein. The fit amplitudes for slower and faster kinetic phases then indicate the number of residues that are well protected and far less protected within each segment. Overall, the results show that half of the residues of monomeric apoA-I are strongly protected from exchange. Given the agreement with CD results for apoA-I at low concentration, which shows 49% helical content (Fig. S1 ), we interpret regions of strong HX protection to represent stable hydrogen-bonded ␣-helical structure. Prior crystallographic results also affirm the presence of a high helical content (10) although CD results indicate that the helical content found in this way is overestimated, not surprisingly given the concentration effects noted before.
The distinction between highly protected and relatively unprotected amide hydrogens in the detailed HX data for the many overlapping peptides was used to specify the beginning and ending boundaries of helical lengths. Given past experience and the observation that many amide sites through a given helical segment show very similar HX protection, we interpret the slow kinetic phase in terms of the control of HX rate by cooperative helix unfolding reactions. When compared to the reference HX curve expected for the peptide in an unstructured condition (k ref ), the fit rate (k ex ) quantifies the degree of structural protection in terms of the stabilization free energy of each helical length against cooperative unfolding (⌬G HX ϭ ϪRT ln (k ex / k ref ) ϭ RT ln Pf). Apparent HX protection factors (Pf) found for sequence positions throughout the apoA-I length range from 2 to 9 for unstructured lengths and up to 5 ϫ 10 4 for strongly protected regions. Fig. 2 shows HX results obtained for two overlapping apoA-I fragments. The 10-residue peptide fragment 1-10 has only five measurable amide hydrogens because it contains three proline residues (residue 3, residue 4, and residue 7), which have no amide hydrogen; and two other positions, the N-terminal amino group and the amide hydrogen on residue 2, are expected to exchange rapidly and lose their D-label during the analysis (27) . The same enumeration holds for all peptide fragments. The five measurable hydrogens in fragment 1-10 all exchange rapidly with a fit protection factor of 4, relative to the reference curve, as is seen also for peptide 4-10 ( Fig. S3A) . The small HX protection factor and high proline content point to a lack of ordered structure in the N-terminal segment.
The overlapping fragment 1-18 ( Fig. 2) shows the same five minimally protected residues, exchanging at the same rate, plus another eight that exchange with Pf 1,200. These results suggest a stable helical length with the amide NH of residue 11 as the first protected hydrogen, evidently hydrogen bonded to the main chain carbonyl of Pro7 (i to i-4). In this case, residues 8, 9, and 10 form the first turn of helix 1 with amide hydrogens not protected by a hydrogen-bond acceptor. The same conclusion is validated by HX data for a number of overlapping fragments shown in Fig. S3A (1-12, 1-13, 1-14, 1-16, 1-17, 1-18, 3-12, and 3-18). The biexponential fit for all of these peptides shows five rapidly exchanging amide hydrogens (4.9 to 5.6 H total range) with a small protection factor (Pf 4 to 9 total range) that are evidently located within the segment 1-10, and well-protected Results for two overlapping peptide fragments chosen to illustrate the analysis. The measured time course of H-to-D exchange (data points) for each fragment is compared with its reference curve computed for the case of no protection. The reference curve for any given peptide was fit by a stretched monoexponential HX time course (␤ Ϸ 0.8, see Methods) since even unprotected amide hydrogens exchange at different rates that depend on their nearest neighbor side chains (27) . Measured HX data in this and other figures are fit by either one or two stretched exponentials using the same stretching factor found for the reference curve. The HX protection factor of any sequence length is obtained by comparing the rate constant of each measured kinetic phase with the reference curve for that sequence. The high reproducibility of the measured data are shown by the agreement between multiple overlapping fragments obtained for the same segment, as for the segment shown, and by the agreement among the various data points because each one represents an independent experiment. Conditions were pD 7, 5°C, 2.5 M freshly prepared apoA-1. Uncertainty is the result of experimental error in amplitude measurements (ϳ5% of the peptide length) and to a few apparent inconsistencies. The stability reported for each helix averages the free energy estimates obtained from all fragments that are fully contained within the helical region and the slower phase of fragments that span a helix boundary. This averaging is equivalent to using the geometric rather than the arithmetic mean of the measured protection factors, which assumes that errors in measured Pf are logarithmic rather than linear. The effect is to make the calculated value for ⌬G HX somewhat lower. *The breaks in helical structure at residues 66 and 79 may instead represent regions of reduced stability with ⌬G HX Ͻ 2 kcal/mol (see text).
† See text for discussion of residues 179 to 184. residues indicating helical structure in the subsequent length. A sharp decrease in protection for peptides starting with residue 43 (peptides 43-49, 43-50) signals the termination of helix 1 at residue 44 Ϯ 2. The fact that the slow phase of all of the peptides spanning helix 1 show similar Pf (1,000 to 6,000) indicates that HX is determined by a cooperative unfolding reaction that entrains essentially the whole helix. A tailing off of the Pf to lower values near the C terminus of helix 1 suggests the presence of some helix fraying.
This well-defined example provides some valuable interpretive guidance. Unstructured segments show minimal protection against HX with Pf values that still tend to be a bit greater than the theoretical value of unity. Sharply defined biexponential behavior with Pf switching from near unity to much higher values clearly marks a disorder/order boundary. More subtle nonmonoexponential curves seen for some peptides that appear to be wholly derived from a helical region can impose some ambiguity in interpretation. Past experience suggests that the faster phase may be the result, in part, of local fluctuations or of helix fraying that can expose a small number of amides to faster exchange than is provided by the more ponderous larger scale whole helix unfolding reaction (see Discussion). , indicating that residues 116-126 are not hydrogen bonded. It follows that the protected helix terminates at residue 115. This structured segment (residues 58-115) is very long so we analyzed this segment for regions of low Pf that may represent some possible short breaks (see below). We take these breaks to potentially define the boundaries of helices 2 to 3 and 3 to 4.
Minimally protected residues starting at residue 116 and extending to residue 151 (fragments 114-126, 115-125, 119-137, and 135-151) define an interhelical length. The numbers of protected hydrogens in fragments 125-158 and 127-158 ( (Fig. S3C) .
Peptide fragments that span the C-terminal sequence 199-243 exhibit minimal protection ( Fig. 3 and Fig. S3C ), indicating that this long segment is disordered. In agreement, a prior HX study of apoA-I showed fast exchange in the C-terminal domain (28) .
Potential Helix Breaks. Some features such as the assignment of short sections with low Pf are less clear. Within the long middle helical length (residues 58-115) just described, peptides 57-71, 58-71, 60-71, 61-71, and 64-71 all show biexponential exchange behavior with three or four minimally protected residues (Pf Ͻ12). It follows that these minimally protected residues must be located between residues 64 and 71. Several peptides beginning with residue 72 (72-91, 72-92, 72-103, and 72-104) all show high protection throughout. Protection of their first two residues, 72 and 73, is intrinsically ambiguous. Taken together, these results suggest a break in the long ordered segment spanning residues 58-115 of three to six residues located somewhere between 64 and 73. It seems likely that the break begins at Pro66, and that helix 3 starts at the carbonyl group of residue 70 (Pf Ϸ7,000). There is some inconsistency in the results for peptide 51-71, which shows eight minimally protected residues, all of which should be accounted for by the absence of protecting structure before residue 60, and therefore does not support the existence of a break at 66-70.
Because the remaining ordered segment 74-115 would still represent a very long single helix, we searched for other short regions of low Pf that might represent break sites. The short fragment 75-82 (Fig. S3B ) contains three residues with low protection (Pf 12). Since residues 75 and 76 are invisible, the three minimally protected residues are located in the region 77-82. In support of this assignment, fragments 75-88, 76-89, 76-92, and 76-104 that encompass this site all contain three to four residues exhibiting low Pf. These results suggest a region of reduced stability that may include a break in helical structure around Gly 81. Our helix numbering will assume that this break exists, so that we refer to protected structure beginning at residue 81 as helix 4. Note that the short breaks between helices 2 and 3 and between helices 3 and 4, which may represent turns, are more well defined as to the length of the break with three to four residues unprotected, rather than the exact location.
The fragment 178-203 mostly exchanges fast (Pf Ͻ10 for 21 of 24 residues) but 3 residues do not exchange within our experimental time scale (Pf Ͼ50,000) (Fig. S3C) . In agreement, peptides 190-203, 190-211, and 190-213, and possibly 190-219 and 190-222 all appear to show Ϸ3 extremely slowly exchanging residues whereas fragments 199-210 and 199-212 both clearly show fast exchange with Pf Ͻ5. One interpretation is that helix 5 ends at residue 178 and there are 3 highly protected residues in the range of 192-203. It is also possible that the apparent protection seen in peptides 190-203 and 190-211 is due to some unexplained error. In this case helix 5 would extend to residue 183 (3 residues seen to be protected in peptide 178-203 ϩ 2 unseen N-terminal residues).
The role of proline residues is interesting. Helix 1 starts after Pro 7 and helix 2 ends at Pro 66. Prolines at 99 and 165 do not appear to disrupt the hydrogen bonding of neighboring residues in helices 4 and 5 but they will impose a kink in the helix direction.
Discussion
Structure. The present HX experiments with monomeric lipidfree human apoA-I at physiologically pertinent concentration (2.5 M, 5°C) identify four or five separate ␣-helical segments with the boundary positions shown in Table 1 and Fig. 3 . At 25°C (Fig. S4) , intrinsic chemical HX rates are faster so that only the more highly protected residues can be measured but the available data are consistent with the 5°C data (Fig. S3) .
Helical lengths are recognized as a continuous stretch of residues that are well protected and exchange their amide hydrogens much more slowly than would be expected for freely exposed amides, whereas interhelical lengths are minimally protected. The break between helical and nonhelical residues is most obvious when a sizeable length of unprotected chain is present and a clear discontinuity in HX rate, with Pf values differing by 100-fold and more, can be seen for fragments that cross the helix boundary. This is true of the break between helices 1 and 2 and between helices 4 and 5. Interhelical regions are shorter and the discrimination is more subtle between helices 2 and 3 and most particularly between helices 3 and 4.
The total of 116 Ϯ 8 helical residues in the 243-residue apoA-I polypeptide indicates a helix content of 48 Ϯ 3%, consistent with CD data for wild-type apoA-I and the deletion mutant ⌬190-243 (9, 11) at low concentration. All helices are located in the N-terminal domain between residues 1 and 178. The C-terminal residues 186-243 are disordered (Table 1) .
Prior Studies. The placement of helical structure in the Nterminal domain of apoA-I and disordered chain in the C-terminal domain (Table 1 , Fig. 3 ) agrees with previous mutational analyses and modeling studies (11, 13, 29, 30, 31) . Also, the detection by HX of the disordered region spanning residues 116-146 between helices 4 and 5 (Table 1) is consistent with studies of apoA-I (⌬121-142) mutants (36) . There is less agreement with the order-disorder boundaries previously found by crystallography (10) and EPR (32, 33 ). An X-ray study of apoA-I in the crystal form (2A01) (10) found six amphipathic ␣-helices. EPR studies of intact apoA-I and long isolated apoA-I fragments indicated both ␤-strand and ␣-helical segments (32, 33) . These results are compared in Fig. 4 .
The X-ray results point to a total ␣-helix content of about 80%, in conflict with CD measurements, which find only 50% helix, perhaps because of the tendency to stabilize interacting amphipathic helices when apoA-I is packed into a crystal structure. Nevertheless the HX results are similar in some ways to the crystallographic structure. Helix 1 identified in this work is similar to the crystal structure, and helices 2 and 3 span a region similar to the second helix in the crystal structure. Helix 4 does not correspond to a helix in the crystal structure but helix 5 is similar to helix 4 in the crystal structure. Helices 4 and 5 in the HX structure are located near helices predicted in a homology model of lipid-free apoA-I (13). Both methods support the presence of stabilizing helix bundle interactions.
The HX results disagree with previous EPR results for apoA-I (Fig. 4) . By comparison, HX and EPR assignments of order/ disorder boundaries were in excellent agreement in the ␣-synuclein polypeptide in amyloid structure (34) . The present discrepancies appear to be the result of the self-association of apoA-I at the higher concentration required for EPR experiments (Ϸ3 mg/mL or 100 M) (32, 33) . One can also consider possible perturbations of the delicately balanced apoA-I structure due to the mutations, spin label attachment, and/or the fragmention approach used in the EPR studies.
Stability. Table 1 includes measured helical stabilities. The stability measured (⌬G HX 3 to 5 kcal/mol) is far greater than can be attained by unsupported helices (35) . This strongly suggests that the helical lengths are organized into a mutually stabilizing helix bundle, as has been observed by crystallography (10) and fluorescence measurements (30, 31) . Stability may also be promoted by favorable cross-helix ion-pair interactions, as has been proposed before for apoA-I (36). The amino acid sequence indicates that the more stable helices 3, 4, and 5 (Table 1) contain several stabilizing ion-pair interactions whereas the relatively unstable helices 1 and 2 contain none. Overall, the stability found is in good agreement with the results of denaturant melting experiments with urea and GdmCl, which indicate a global stability in the range of 4 to 6 kcal/mol (11, 37) .
It is interesting that the apparently nonhelical segments exhibit some small protection against HX, with protection factors in the range of 2 to 9, greater than the value of unity expected for a wholly unprotected random coil. This HX slowing may represent some small protection because of collapse against other structured regions or perhaps because of the rigidly constrained phi/psi angles (38) of the four unprotected residues in the N-terminal turn of each helical length.
Structural Dynamics. It appears that the protected hydrogens of apoA-I are exposed to solvent exchange by concerted transient unfolding reactions of large segments, perhaps an entire helix or even an entire helical bundle because a transiently unsupported helix could not maintain stability. Accordingly, the relative stabilities of the different helices may indicate which ones interact. Helices 1 and 2 have similar low stabilities suggesting that they may interact and unfold together. The more stable helices 3, 4, and 5 may form another mutually supporting group.
The measured stabilization-free energies, in the range of 3 to 5 kcal/mol, correspond to an equilibrium constant K unfold Ϸ 10 Ϫ3 . This means that the native helices, in dynamic equilibrium with their unfolded form, spend about 0.1% of the time unfolded. Stability is even lower at physiological temperature as shown for a representative fragment in Fig. S5 . For comparison, helices built into globular proteins are often more stable than this by well over 1,000-fold (as measured by native state HX) (39) . Because the folding of such structures can occur on a millisecond time scale (40) , and K unfold ϭ k unfold /k refold Ϸ 10 Ϫ3 , the helices in apoA-I are likely to unfold (and refold) on a time scale of seconds. The dynamic nature of apoA-I structure and its relative instability presumably explain the facile ability of its helical segments to unfold and remodel during HDL formation and maturation. Similarly, although the apoA-I C-terminal domain is disordered in dilute solution, it appears poised to form an amphipathic helix upon interaction with lipid particles (32) or other apoA-I molecules.
HX Mechanism. The HX calculation used to obtain helix stability assumes EX2 behavior where HX rate is determined by the fraction of time that structure is transiently unfolded, equal to the unfolding equilibrium constant (25) . This requires that the helix refolding rate is greater than the unprotected HX rate at the conditions used (Ϸ0.1 s). The EX2 assumption is also supported by the unimodal fragment isotopic envelopes ( Fig. 1 E and F) seen by mass spectrometry throughout the HX time scale for all fragments. EX1 behavior, where helix refolding is slower than the unprotected HX rate, would generate bimodal isotopic distributions.
In many cases it was necessary to fit the HX results for given peptides by a biexponential kinetic curve, even for peptides that do not cross a helical boundary but appear to be wholly contained within a given helix. This does not necessarily indicate two distinctly separate groupings but only that the spread in HX rates is greater than can be adequately represented by a single exponential even when supplemented by the stretching factors used. The behavior observed seems to reflect a central role for cooperative, apparently whole helix unfolding reactions but with some superimposed effects that cause additional dispersion in A B C Fig. 4 . Comparison of the HX-derived secondary structure of lipid-free apoA-I and published secondary structure analyses. The 80% ␣-helical content found in the crystal structure (pdb file 2A01) (10) is contradicted by HX results for monomeric apoA-I, although some correspondence in helix positions can be noted. EPR analysis for secondary structure information was obtained for intact lipid-free apoA-I and a C-terminal fragment at Ͼ0.1 mM concentration (32, 33) where the protein self-associates and CD and HX (Fig. S2B) show increased helix content.
HX rates. Similar rate dispersion is often seen in unfoldingdependent HX measured by native state HX experiments for both global and subglobal unfolding reactions. Possible effects include helix fraying and the intrusion of local fluctuations (41) that might separately deprotect one or a few amides in the middle of a helical segment. Glycine residues have a special ability to enhance local fluctuations (42) and their positions are noted in Fig. 4 . These mechanisms would make HX of some sites within a helical segment faster. The possible acquisition of alternative protecting interactions in the transiently unfolded state might make HX slower, but apparently only by a small amount as is seen for the permanently disordered segments in apoA-I.
The present results reflect on the widespread belief, especially prevalent in the HX mass spectrometry field, that HX rates are dominated by solvent accessibility (17) . Contrary to this view, the present (and previous) results indicate that solvent access in the native state is not a determining factor. Even when the HX rate of structurally protected hydrogens is slowed by 10 4 -fold, the surface-exposed hydrogens, in direct contact with bulk solvent, do not exchange much faster than the buried ones. These observations are consistent with the view that the critical event that allows exchange is hydrogen-bond separation and exposure, and not solvent access in the native state.
Materials and Methods
Methods. HX experiments used the fragmentation-separation method (14) with analysis by mass spectrometry (15, 16) . Proteolytic fragments were identified by MS/MS analysis repeated in each day's experiments to calibrate chromatographic retention times. Time-dependent HX experiments were performed at pD 7.0 (5°C, 25°C, 37°C). The experimental protocol is illustrated in Fig. 1 .
Protein solutions were preequilibrated at the desired temperature. To initiate H-to-D exchange, protein samples freshly dialyzed from 6 M GdmCl were diluted 10-fold into D 2O buffer to give an apoA-I concentration of 2.5 M. The exchange reaction was quenched by adding each timed sample (50 L) to a sample tube in ice with 7.0 L of 99% formic acid to lower the pD to 2.6. Samples were immediately injected into the on-line fragmentationseparation/MS analysis system (volume flow 50 L/min). Samples passed through an immobilized protease column onto a C18 trap column (2.5 ϫ 0.5 mm), followed by a 3-min wash, elution (6 L/min, 12-50% acetonitrile gradient with 0.1% formic acid at pH 2.5 and 0°C) into and through an analytical C18 HPLC column (75 mm ϫ 0.3 mm), and injection by ESI into the mass spectrometer. Pepsin and fungal protease XIII were used in separate experiments yielding about 50 useful fragments for each.
Measured fragment-bound deuterium was corrected for the 90% initial deuterium solvent and for D-loss (back exchange) during the analysis by calibrating the D-recovery for each peptide fragment when starting with a fully deuterated apoA-I sample. For the analysis of HX protection factors, which yields the stability of protecting structure, the measured HX rate curve for each peptide was compared to a reference curve predicted (27) (2 ϫ 20 mm, or 1 ϫ 20 mm) .
ApoA-I was chromatographically purified from human plasma HDL obtained by sequential ultracentrifugation, as described before (3, 4) . Concentration was measured by absorbance ( ϭ 1.13 mL⅐cm⅐mg Ϫ1 at 280 nm). CD spectra were recorded on a Jasco J-810 spectropolarimeter, as described before (5) . All pH electrode readings in D 2 O were converted to pD by adding 0.4 (6).
The HX Experiment. To prepare samples for HX experiments, lipid-free apoA-I in 6 M GdmCl was dialyzed against 25 mM phosphate buffer (pH 7.0). The monomeric status of freshly dialyzed lipid-free apoA-I at 0.7 mg/mL (25 M) and 0.07 mg/mL (2.5 M) was confirmed by cross-linking experiments (EDC at 50-or 100-fold molar excess; 10 min at 25°C with gentle mixing; Fig. S2 ). Samples were analyzed by nonreducing Tris-glycine SDS/PAGE in a 4-20% precast gradient gel (Invitrogen), with staining by Coomassie blue.
HX experiments used the fragmentation-separation method (7) with analysis by mass spectrometry (8) (LTQ Orbitrap XL mass spectrometer; ThermoFisher Scientific). Proteolytic fragments were identified by MS/MS analysis (CID; SEQUEST software from ThermoFisher Scientific), repeated in each day's experiments to calibrate chromatographic retention times. Time-dependent HX experiments were performed at pD 7.0 (5°C, 25°C, 37°C). All solutions were preequilibrated at the desired temperature. The experimental protocol is illustrated in Fig. 1 . To initiate H-to-D exchange, freshly prepared samples were diluted 10-fold into D 2 O buffer to give an apoA-I concentration of 2.5 M. The exchange reaction was quenched by adding each timed sample (50 L) to a sample tube in ice with 7.0 L of 99% formic acid to lower the pD to 2.6. Samples were immediately injected into the on-line fragmentation-separation/MS analysis system (volume flow 50 L/min). Proteolytic fragmentation used an acid protease immobilized in a protease column. Samples passed through the protease column onto a C18 trap column (2.5 ϫ 0.5 mm), followed by a 3-min wash. Fragments were eluted (6 L/min, 12-50% acetonitrile gradient with 0.1% formic acid at pH 2.5 and 0°C) into and through an analytical C18 HPLC column (75 mm ϫ 0.3 mm), and injected by ESI into the mass spectrometer. Pepsin and fungal protease XIII were used in separate experiments yielding about 50 useful fragments for each. The time elapsed between quenching the HX reaction and the final MS scan was 6 to 14 min.
Data Analysis. Mass spectra from the exchange experiments were analyzed using the DXMS software program (Sierra Analytics). The program uses a curve-fitting approach to assign the centroid m/z values of the isotopic cluster envelopes of a set of peptides selected from a list previously identified by SEQUEST analysis of MS/MS data. Assignments are based on HPLC retention times (Ϯ0.5 min) measured each day for 100%-H samples, charge state, and mass (tolerance Ϯ 0.01 Da, including accounting for the number of deuterons in the deuterated samples). The program calculates a data quality score and displays the measured and best fit isotopic envelope for each peptide. The time-dependent average number of deuterons exchanged onto each peptide segment was obtained as the difference in centroid mass between the fully H and experimental sample after adjusting for peptide charge state.
Measured fragment-bound deuterium was corrected for the 90% initial deuterium solvent and for D-loss (back exchange) during the analysis by calibrating the D-recovery for each peptide fragment when starting with a fully deuterated apoA-I sample handled exactly as above. This simple back exchange correction assumes uniform loss within each peptide fragment which is satisfactory so long as the D-loss is small. Recovery of deuterium label was usually in the 70-80% range although a few fragments were consistently lower (60-70%).
For the analysis of HX protection factors, the measured HX rate curve for each peptide was compared to a reference curve predicted (9, 10) for the case of no protection, shown as a dashed curve in each data panel. The reference curves were represented by a stretched exponential, fit as D t ϭ N [1 Ϫ exp(Ϫk ex t) ␤ ] where time-dependent deuteron uptake (D t ) approaches the number of exchangeable amide sites (N) in each peptide fragment in an exponential way but modified by a stretching factor (␤ Յ 1), which is pertinent because the hydrogens in any given amino acid sequence exchange over a range of rates determined by nearest neighbor effects (9) . Depending upon the amino acid composition, the stretching factor, ␤, varied in the range 0.8 Ϯ 0.1. The measured HX data were fit by similarly stretched mono-or biexponential curves as necessary, using the stretching factor found for each peptide. The stability of protecting structure that must unfold to allow exchange was determined by comparing each measured exchange rate curve with the rate curve expected for the freely exposed peptide (9, 10) , and (C) 37°C. After correcting for the effect of temperature on the intrinsic chemical HX rate, the apparent ⌬G of helix stability at 5°C and 25°C is 5.3 and 3.8 kcal/mol, respectively, and less at 37°C.
